# LUCENTIS

NDC: 50242-080
Generic name: RANIBIZUMAB
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVITREAL
Marketing started: 20060630

FDA application: BLA125156

## Active ingredients

- RANIBIZUMAB: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-080"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-080
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=de4e66cc-ca05-4dc9-8262-e00e9b41c36d